Search

  • HOME
  • Search
Prostate Cancer
Original Article
594
Assessing Patient Risk, Benefit, and Outcomes in Drug Development: A Decade of Abiraterone Clinical Trials
Matthew Rashid, Eli Oldham, Griffin K. Hughes, Andriana M. Peña, Chase Ladd, Brooke Gardner, Ryan McIntire, Bradley Johnson, Jordan Tuia, Alyson Haslam, Vinay Prasad, Matt Vassar
Journal of Urologic Oncology. 2024;22(3):211-223.   Published online November 30, 2024
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Article
3
Is the Expression of p53, c-erb-B2 and Ki-67 Influence the Prognosis of the Non-muscle Invasive Urothelial Bladder Cancer?
Seok Hyun Kang, Hyun Jin Jung, Eun Kyoung Yang, Jae Shin Park, Hoon Kyu Oh, Duk Yoon Kim
Korean J Urol Oncol. 2016;14(2):69-75.   Published online August 30, 2016
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    

Journal of
Urologic Oncology

Print ISSN: 2951-603X
Online ISSN: 2982-7043



Editorial Office
Department of Urology, Seoul National University Hospital, Seoul National University College of Medicine,
101 Daehak-ro, Jongno-gu, Seoul 03080, Korea
TEL: +82-2-2072-0817,   FAX: +82-2-742-4665   Email: journal@e-juo.org
Korean Urological Oncology Society
50-1 Yonsei-ro, Seodaemun-gu, Seoul 03722, Korea
Tel: +82-2-704-8574, E-mail: kspe.editor@gmail.com

Copyright © The Korean Urological Oncology Society.

Developed in M2PI